Paragon Vision Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Paragon Vision Sciences's estimated annual revenue is currently $36.2M per year.
- Paragon Vision Sciences's estimated revenue per employee is $270,000
Employee Data
- Paragon Vision Sciences has 134 Employees.
- Paragon Vision Sciences grew their employee count by -11% last year.
Paragon Vision Sciences's People
Name | Title | Email/Phone |
---|
Paragon Vision Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.7M | 25 | -7% | N/A | N/A |
#2 | $9.7M | 45 | 10% | N/A | N/A |
#3 | $9.3M | 43 | -25% | N/A | N/A |
#4 | $9.9M | 93 | 16% | N/A | N/A |
#5 | $3.5M | 65 | 14% | N/A | N/A |
#6 | $76.3M | 257 | 7% | N/A | N/A |
#7 | $8.9M | 41 | -5% | N/A | N/A |
#8 | $15.1M | 62 | 41% | N/A | N/A |
#9 | $16M | 66 | 2% | N/A | N/A |
#10 | $15.1M | 62 | 41% | N/A | N/A |
What Is Paragon Vision Sciences?
Paragon Vision Sciences is a world leader in orthokeratology (ortho-k), specialty contact lenses and oxygen permeable contact lens materials. As a progressive manufacturer of a full range of oxygen permeable (GP) materials used in the manufacturing of contact lenses, Paragon Vision Sciences developed Paragon CRT® Contact Lenses for use in orthokeratology. Approved by the FDA in June of 2002 for overnight wear, Paragon CRT® Contact Lenses are the preferred choice by an elite, global group of eye care practitioners to manage myopia (nearsightedness).
keywords:N/AN/A
Total Funding
134
Number of Employees
$36.2M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Paragon Vision Sciences News
Essilor Group, Johnson & Johnson, Luxottica, Novartis, Valeant Pharmaceuticals, Bausch and Lomb, Menicon, Paragon Vision Sciences,...
Ltd., Paragon Vision Sciences, Bausch & Lomb, OPRI Inc., PPG Optical, Benz Research & Development, X-Cel Optical Company.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.1M | 134 | 58% | N/A |
#2 | $39.4M | 134 | 12% | N/A |
#3 | $20.4M | 136 | 17% | N/A |
#4 | $41.6M | 140 | -23% | N/A |
#5 | $52.6M | 145 | 26% | N/A |